Systemic coadministration of chloramphenicol with intravenous but not intracerebroventricular morphine markedly increases morphine antinociception and delays development of antinociceptive tolerance in rats.
暂无分享,去创建一个
C. Nielsen | M. Smith | A. Wright | M. Lim-Fraser | M. Lau | Maree T. Smith | Carsten K. Nielsen | Andrew W. E. Wright | Michael Lau
[1] S. South,et al. Apparent insensitivity of the hotplate latency test for detection of antinociception following intraperitoneal, intravenous or intracerebroventricular M6G administration to rats. , 1998, The Journal of pharmacology and experimental therapeutics.
[2] Maree T. Smith,et al. The intrinsic antinociceptive effects of oxycodone appear to be κ-opioid receptor mediated , 1997, Pain.
[3] A. Somogyi,et al. The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. , 1996, Drug metabolism reviews.
[4] M. J. Olaso,et al. Lack of morphi-ne-6-glucuronide antinociception after morphine treatment Is morphine-3-glucuronide involved? , 1996, Pain.
[5] Thomas J. Morrow,et al. Medial frontal cortex lesions selectively attenuate the hot plate response: possible nocifensive apraxia in the rat , 1996, Pain.
[6] R. Thurman,et al. Isolated perfused liver. , 1996, Pharmaceutical biotechnology.
[7] J. Scherrmann,et al. Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: a microdialysis study , 1995, British journal of pharmacology.
[8] Maree T. Smith,et al. Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat , 1995, Pain.
[9] A. Evans,et al. The Disposition of Morphine and Its Metabolites in the In‐situ Rat Isolated Perfused Liver , 1995, The Journal of pharmacy and pharmacology.
[10] K. Foley,et al. Cancer Pain Relief , 1995, Springer Netherlands.
[11] A. Rane,et al. Tricyclic antidepressants inhibit opioid receptor binding in human brain and hepatic morphine glucuronidation. , 1994, Pharmacology & toxicology.
[12] Maree T. Smith,et al. Quantitation of Morphine, Morphine‐3‐Glucuronide, and Morphine‐6‐Glucuronide in Plasma and Cerebrospinal Fluid Using Solid‐Phase Extraction and High‐Performance Liquid Chromatography with Electrochemical Detection , 1994, Therapeutic drug monitoring.
[13] M. Smith,et al. The antinociceptive potencies of oxycodone, noroxycodone and morphine after intracerebroventricular administration to rats. , 1994, Life sciences.
[14] S. Bartlett,et al. The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. , 1994, Life sciences.
[15] S. Finger,et al. Medial Frontal Cortex Lesions: Deficits and Treatment with Nimodipine , 1993, Experimental Neurology.
[16] E. Kalso,et al. Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats. , 1993, European journal of pharmacology.
[17] A. Dickenson,et al. Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological study , 1993, Pain.
[18] T. Hedner,et al. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat , 1992, Pain.
[19] V. Ravindranath,et al. Administration of testosterone alleviates the constitutive sex difference in rat brain cytochrome P-450 , 1991, Neuroscience Letters.
[20] Maree T. Smith,et al. Morphine-3-Glucuronide — A potent antagonist of morphine analgesia , 1990, Pain.
[21] A. Rane,et al. Sex differences and endocrine regulation of morphine oxidation in rat liver. , 1990, Biochemical pharmacology.
[22] K. Suzuki,et al. Spinal antinociception: Comparison of a dermorphin tetrapeptide analogue, [d-arginine2, sarcosine4]-dermorphin (1–4) and morphine in rats , 1990, Neuropharmacology.
[23] C. von Bahr,et al. Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors. , 1990, Pharmacology & toxicology.
[24] B. Burchell,et al. The enantioselective glucuronidation of morphine in rats and humans. Evidence for the involvement of more than one UDP-glucuronosyltransferase isoenzyme. , 1989, Biochemical pharmacology.
[25] J. Miners,et al. In vitro evidence for the involvement of at least two forms of human liver UDP-glucuronosyltransferase in morphine 3-glucuronidation. , 1988, Biochemical pharmacology.
[26] T. Yaksh,et al. High Doses of Spinal Morphine Produce a Nonopiate Receptormediated Hyperesthesia: Clinical and Theoretic Implications , 1986, Anesthesiology.
[27] Lawrence A. Trissel,et al. Handbook on Injectable Drugs , 1983 .
[28] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[29] L. Brady,et al. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats. , 1982, The Journal of pharmacology and experimental therapeutics.
[30] P. Flecknell,et al. Experimental and surgical technique in the rat. , 1980 .
[31] C. Pinsky,et al. Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity , 1979, Brain Research.
[32] M. Gibaldi. Biopharmaceutics and clinical pharmacokinetics , 1977 .
[33] D. Marquardt. An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .
[34] N. B. Eddy,et al. Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. , 1953, The Journal of pharmacology and experimental therapeutics.